Risk of Reductions in Public Subsidy Programs
First written in FY2017. 2 of 4 entries say "Restated". Latest entry: FY2023.
Human Metabolome Technologies moved to the "Worse" side of this theme in 2023.
0 other companies' latest entry also says "Reframed".
- FY2023ReframedAnnual report
「To mitigate the effects of these seasonal fluctuations, our Group will seek to expand orders from private-sector companies that are less dependent on subsidies and from overseas customers whose fiscal year-ends occur at different times.」
Rather than presenting a reduction in public subsidy programs itself as a standalone risk, the company positions it in terms of dependence on subsidies and seasonal fluctuations, together with mitigation through private-sector and overseas orders. - FY2020RestatedAnnual report
「If public subsidy programs are reduced in the future due to changes in social conditions, this could affect the results of operations of our Group.」
The company continues to disclose the risk that a reduction in public subsidy programs could affect its results of operations. - FY2019RestatedAnnual report
「If public subsidy programs are reduced in the future due to changes in social conditions, this could affect the results of operations of our Group.」
The company continues to disclose the risk of a reduction in public subsidy programs. - FY2017First statedAnnual report
「If public subsidy programs are reduced in the future due to changes in social conditions, this could affect the results of operations of our Group.」
Because the research and development activities of universities and public research institutions depend on public subsidies, the company identifies the impact of a reduction in these programs as a risk.